Mini Review
Published on 31 Mar 2020
Role of ADAM10 as a CD30 Sheddase in Classical Hodgkin Lymphoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2020.00398
- 7,193 views
- 14 citations
34 articles related to "Cd30"
Articles
Original Research
Published on 25 Sep 2017
CD30 Is Dispensable for T-Cell Responses to Influenza Virus and Lymphocytic Choriomeningitis Virus Clone 13 but Contributes to Age-Associated T-Cell Expansion in Mice
in T Cell Biology
Frontiers in Immunology
doi 10.3389/fimmu.2017.01156
- 4,874 views
- 4 citations
Review
Published on 22 Dec 2023
Mechanism of action and therapeutic targeting of CD30 molecule in lymphomas
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1301437
- 5,941 views
- 11 citations
Clinical Trial
Published on 02 Feb 2021
CD19 and CD30 CAR T-Cell Immunotherapy for High-Risk Classical Hodgkin’s Lymphoma
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2020.607362
- 7,683 views
- 11 citations
Brief Research Report
Published on 30 Jul 2021
CD30-Positive Extracellular Vesicles Enable the Targeting of CD30-Negative DLBCL Cells by the CD30 Antibody-Drug Conjugate Brentuximab Vedotin
in Molecular and Cellular Pathology
Frontiers in Cell and Developmental Biology
doi 10.3389/fcell.2021.698503
- 6,609 views
- 10 citations
Original Research
Published on 04 Jun 2025
CD30 associates with EBER-EBV but not HCV-NS3 in T-cell non-Hodgkin lymphoma
in Translational Virology
Frontiers in Virology
doi 10.3389/fviro.2025.1583648
- 1,216 views
Original Research
Published on 21 Jul 2020
Essential Role for CD30-Transglutaminase 2 Axis in Memory Th1 and Th17 Cell Generation
in T Cell Biology
Frontiers in Immunology
doi 10.3389/fimmu.2020.01536
- 5,659 views
- 9 citations
Original Research
Published on 14 Aug 2023
Novel anti-CD30/CD3 bispecific antibodies activate human T cells and mediate potent anti-tumor activity
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1225610
- 7,614 views
- 8 citations
Review
Published on 22 Sep 2023
Updates in pathobiological aspects of anaplastic large cell lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1241532
- 6,371 views
- 8 citations
Case Report
Published on 09 Jul 2025
Treatment of relapsed or refractory Hodgkin’s lymphoma with lenalidomide combined with PD-1 monoclonal antibody: a case report and literature review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1632039
- 1,747 views
- 1 citation
Original Research
Published on 17 Apr 2023
LCL161 enhances expansion and survival of engineered anti-tumor T cells but is restricted by death signaling
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1179827
- 4,196 views
- 1 citation
Original Research
Published on 24 Sep 2019
Development of a Bispecific Antibody Targeting CD30 and CD137 on Hodgkin and Reed-Sternberg Cells
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2019.00945
- 6,360 views
- 20 citations
Case Report
Published on 29 May 2020
Follicular Dendritic Cell Sarcoma With Co-Expression of CD4 and CD30 Mimics Anaplastic Large Cell Lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2020.00876
- 7,437 views
- 10 citations
Original Research
Published on 13 Jul 2023
In vitro differentiated human CD4+ T cells produce hepatocyte growth factor
in T Cell Biology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1210836
- 7,148 views
- 2 citations
Perspective
Published on 25 Feb 2022
Advances in Hodgkin Lymphoma: Including the Patient’s Voice
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.855725
- 5,247 views
- 4 citations
Case Report
Published on 03 Jan 2024
Case report: EBV-positive epithelioid follicular dendritic cell sarcoma with CD30 expression: a highly challenging diagnosis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1321565
- 2,169 views
- 1 citation